APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 149 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $654 | -58.3% | 17,200 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $1,567 | +58.4% | 17,200 | +14.7% | 0.01% | +33.3% |
| Q1 2023 | $989 | +59.3% | 15,000 | +25.0% | 0.01% | +50.0% |
| Q4 2022 | $621 | -99.9% | 12,000 | +2.6% | 0.00% | -20.0% |
| Q3 2022 | $799,000 | +51.0% | 11,700 | 0.0% | 0.01% | +66.7% |
| Q2 2022 | $529,000 | -22.3% | 11,700 | -12.7% | 0.00% | -25.0% |
| Q1 2022 | $681,000 | +7.4% | 13,400 | 0.0% | 0.00% | +33.3% |
| Q4 2021 | $634,000 | +43.4% | 13,400 | 0.0% | 0.00% | +50.0% |
| Q3 2021 | $442,000 | -47.8% | 13,400 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $847,000 | +54.3% | 13,400 | +4.7% | 0.00% | +33.3% |
| Q1 2021 | $549,000 | -25.0% | 12,800 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $732,000 | +89.6% | 12,800 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $386,000 | -53.8% | 12,800 | -50.0% | 0.00% | -25.0% |
| Q2 2020 | $836,000 | – | 25,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |